USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Biological Therapeutics, Inc.
Address:
3505 Riverview Circle
Moorhead, MN 56560
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $100,000.00 2

Award List:

THE LONG-TERM OBJECTIVE IS TO PREPARE AN EFFECTIVE LIPOSOME ENCAPSULATED REAGENT WHICH WILL BE PREFERENTIALLY TARGETED TO LIVER MACROPHAGES RESULTING IN MACROPHAGE ACTIVATION FOR THE THERAPY OF METASTATIC HEPATIC DISEASE.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Karl e. swenson , PRINCIPAL INVESTIGATOR
Abstract:
The long-term objective is to prepare an effective liposome encapsulated reagent which will be preferentially targeted to liver macrophages resulting in macrophage activation for the therapy of metastatic hepatic disease. the specific aims are: 1.to produce a lipophilic derivative of the… More

THE LONG-TERM OBJECTIVE OF THE PROPOSAL IS TO CREATE AND EVALUATE THE EFFECTIVENESS OF MONOCLONAL ANTIBODY DIRECTED AGAINST THE RECEPTOR ON MALIGNANT CELLS RECOGNIZED BY ACTIVATED MACROPHAGES.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
James r. hoffman , PRINCIPAL INVESTIGATOR
Abstract:
The long-term objective of the proposal is to create and evaluate the effectiveness of monoclonal antibody directed against the receptor on malignant cells recognized by activated macrophages. macrophages, when activated, recognize and destroy malignant cells. activated macrophages do not recognize… More